1-4 of 4
Mary Akosile
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response Kinetics and Factors Predicting Survival Among Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)

Prajwal Boddu, MD, Christopher Gurguis, MS, Jorge E. Cortes, MD, Mary Akosile, Farhad Ravandi, MBBS, David Sanford, MD, Mark Brandt, BS, Rita Maduike, Tapan Kadia, MD, Hagop M. Kantarjian, MD, Gautam Borthakur, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 27.
https://doi.org/10.1182/blood.V130.Suppl_1.27.27
Published: 2017
Journal Articles

Response and Outcomes of Third-Line Tyrosine Kinase Inhibitor Therapy on Patients with Chronic Phase Chronic Myeloid Leukemia

Maliha Khan, Hagop M. Kantarjian, MD, Jing Ning, PhD, Mary Akosile, Wen Li, Gautam Borthakur, MD, Nitin Jain, MD, Courtney D. DiNardo, MDMSc, William G Wierda, MD PhD, Farhad Ravandi, MBBS, Guillermo Garcia-Manero, MD, Marina Konopleva, MD PhD, Tapan Kadia, MD, Naveen Pemmaraju, MD, Philip A Thompson, MBBS, Naval Daver, MD, Elias J. Jabbour, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2882.
https://doi.org/10.1182/blood.V130.Suppl_1.2882.2882
Published: 2017
Journal Articles

Outcome after Discontinuation of Second Generation Tyrosine Kinase Inhibitors (TKIs) Used As Frontline Therapy for Patients (pts) with Chronic Phase (CP) Chronic Myeloid Leukemia (CML)

Waleed Abdelall, MD, Hagop M. Kantarjian, MD, Devendra KC, MD, Mary Akosile, Gautam Borthakur, MD, Srdan Verstovsek, MD PhD, Naval Daver, MD, Naveen Pemmaraju, MD, Kiran Naqvi, MDMPH, Guillermo Garcia-Manero, MD, Philip A Thompson, MBBS, Alessandra Ferrajoli, MD, Farhad Ravandi, MBBS, Marina Konopleva, MD PhD, Courtney D. DiNardo, MDMSc, Elias J. Jabbour, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5248.
https://doi.org/10.1182/blood.V130.Suppl_1.5248.5248
Published: 2017
Journal Articles

Survival Impact of Patients (Pts) with Chronic Myeloid Leukemia (CML) Due to Failure from the Use of One or More Tyrosine Kinase Inhibitors (TKI)

Mary Akosile, BA, Sherry Pierce, BSN, BA, Mark Brandt, BS, Srdan Verstovsek, MD, Gautam Borthakur, MD, Hagop Kantarjian, MD, Farhad Ravandi, MD, William Wierda, MD PhD, Guillermo Garcia-Manero, MD, Naval Daver, MD, Tapan Kadia, MD, Jan A. Burger, MD PhD, Naveen Pemmaraju, MD, Elias Jabbour, Jorge E. Cortes, MD
Journal: Blood
Blood (2015) 126 (23): 1587.
https://doi.org/10.1182/blood.V126.23.1587.1587
Published: 2015